April 11 (Reuters) - Swiss drugmaker Novartis AG has entered into a licensing deal worth up to $1.01 billion with Arvinas ( ARVN ) to gain access to the U.S. biotech firm's experimental prostate cancer drug, Arvinas ( ARVN ) said on Thursday. Shares of Connecticut-based Arvinas ( ARVN ) rose more than 6% to $39 in premarket trade. The...

MILAN, April 11 (Reuters) - Activist investor Bluebell Capital Partners is proposing to nominate an outgoing Google executive as candidate for the role of CEO of Telecom Italia (TIM), in a challenge to Pietro Labriola's bid for a second term. In a document presenting Bluebell's vision for TIM, seen by Reuters, it proposed Laurence Lafont, the outgoing vice-president for strategic...

08:58 AM EDT, 04/11/2024 (MT Newswires) -- Spotify Technology ( SPOT ) is developing tools that would allow subscribers to edit songs from their favorite artists, The Wall Street Journal reported Thursday, citing people familiar with the discussions. The new tools the audio-streaming company is considering include a playback feature that would allow users to adjust the speed of a...

On Wednesday, Vertex Pharmaceuticals Incorporated ( VRTX ) agreed to acquire Alpine Immune Sciences Inc ( ALPN ) for $65 per share or approximately $4.9 billion in cash.  Alpine’s lead molecule, povetacicept (ALPN-303), is a highly potent and effective dual antagonist of BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand).  Through Phase 2 development, povetacicept has shown potential best-in-class efficacy in IgA...